dihexa human clinical trials data EllieMD dihexa human trials status 2026
Description
Key takeaways include: Obesity drug coverage in Medicaid remains limited, with 13 state Medicaid programs covering GLP-1s for obesity treatment under fee-for-service (FFS) as of January 2026
Type: NNMT Enzyme Inhibitor
Feeling overheated
Margalit, A., Phalen, H., Gao, C., Ma, J., Surech, K
